Kratom shots are small bottles of concentrated liquid extract made from the leaves of the kratom plant (Mitragyna speciosa). They typically come in 15 to 30 mL bottles, similar in size to a 5-hour Energy drink, and contain far higher concentrations of kratom’s active compounds than traditional powder or capsules. They’re sold at gas stations, smoke shops, and online retailers, often marketed for energy or mood support.
What’s Inside a Kratom Shot
The liquid inside a kratom shot is produced by boiling down kratom leaves and filtering out the active alkaloids to create a concentrated extract. That extract is then mixed with purified water, natural flavors (citrus, berry, or mint are common), and preservatives like citric acid. The result is a flavored, drinkable liquid that packs a significant dose of kratom’s key compounds into a few small sips.
The two alkaloids that matter most are mitragynine and 7-hydroxymitragynine (often listed as 7-OH on labels). Mitragynine is the primary alkaloid and usually makes up the bulk of the active content. A typical kratom shot bottle (30 mL, or about three servings) can contain around 225 mg of mitragynine and 9 mg of 7-hydroxymitragynine. A single 10 mL serving from that bottle would deliver roughly 75 mg of mitragynine and 3 mg of 7-OH. Those numbers matter because they’re substantially higher than what most people get from a teaspoon of kratom powder.
How Kratom Shots Affect the Body
Mitragynine acts as a partial agonist at the brain’s mu-opioid receptors, the same receptors targeted by opioid painkillers. “Partial agonist” means it activates those receptors, but not as fully as drugs like morphine or fentanyl. At lower doses, this interaction tends to produce mild stimulant effects: increased alertness, elevated mood, and reduced perception of fatigue. At higher doses, the effects shift toward sedation, pain relief, and relaxation.
7-Hydroxymitragynine is a different story. It’s present in much smaller amounts but is dramatically more potent, acting as a full agonist at those same opioid receptors. Research from the National Institutes of Health found that 7-OH binds to mu-opioid receptors roughly 22 times more tightly than mitragynine does. This compound is largely responsible for the stronger, more opioid-like effects that concentrated kratom products can produce, and it’s also the compound most closely linked to tolerance and physical dependence.
Both alkaloids also interact with the body’s adrenaline-related receptors, which likely contributes to the stimulant effects users report at lower doses.
Shots vs. Powder: Why Potency Matters
The core difference between a kratom shot and loose kratom powder is concentration. Powder requires you to measure out grams of plant material, mix it into a drink, and wait for your digestive system to break it down. A liquid extract has already been broken down and concentrated, so the alkaloids are more readily available.
This makes shots hit faster and harder. Human pharmacokinetic data on kratom tea (the closest comparison to a liquid extract) shows mitragynine reaching peak blood levels in under an hour, with an average of about 50 minutes. Powder in capsule form generally takes longer because the capsule itself needs to dissolve first. The concentrated nature of shots also means it’s easy to consume a much larger dose than intended, especially if you drink the whole bottle rather than a single serving.
Utah State University’s analysis of kratom shots highlights this risk directly: a product that looks like a single-serving energy shot may actually contain three servings, with the full bottle delivering 225 mg of mitragynine. Their guidance suggests keeping mitragynine under 100 mg per serving and under 300 mg per day to reduce the risk of nausea, dizziness, and dependence. They also flag that 7-OH content above 2% of total alkaloids suggests a product that’s been heavily concentrated or synthetically enhanced, carrying greater overdose risk.
Health Risks of Concentrated Kratom
Kratom is not FDA-approved, which means there’s no regulated standard dose, no required testing for contaminants, and no guarantee that what’s on the label matches what’s in the bottle. The FDA has issued multiple safety notices about kratom products, warning of adverse effects including respiratory depression, hallucinations, severe vomiting, aggression, and dangerous withdrawal symptoms.
Liver injury is one of the more serious documented risks. According to the NIH’s LiverTox database, kratom has been linked to rare but clinically significant acute liver damage, with at least two dozen published cases involving jaundice. The pattern typically starts within one to eight weeks of regular use, with fatigue, nausea, itching, and dark urine appearing before the skin and eyes turn yellow. In severe cases, the liver damage can be accompanied by kidney failure and bone marrow toxicity. The NIH rates kratom as a “likely cause” of clinically apparent liver injury.
Higher doses of kratom, the kind easily reached with concentrated shots, can cause elevated blood pressure, rapid heart rate, agitation, and confusion. Overdoses have caused seizures, coma, and death. Because shots pack so much alkaloid content into such a small volume, the margin between a dose that produces mild effects and one that causes serious harm is narrower than with powder.
Dependence and Withdrawal
Regular use of kratom, particularly concentrated products, can lead to physical dependence. This is driven primarily by 7-hydroxymitragynine’s full activation of opioid receptors, which produces tolerance and withdrawal patterns similar to those seen with traditional opioids. Withdrawal symptoms can include muscle aches, irritability, insomnia, nausea, and mood disturbances.
The convenience of shots can accelerate this cycle. Because they’re easy to carry, fast-acting, and pre-measured in a way that feels controlled, users may take them more frequently or in higher amounts than they would with loose powder. A person drinking one full bottle per day is consuming roughly 225 mg of mitragynine, which sits at the upper range of daily intake thresholds that researchers have flagged as concerning.
What to Look for on the Label
If you encounter kratom shots, a few label details can help you gauge what you’re dealing with. Look for the milligram amount of mitragynine per serving and per bottle. Products that only list “kratom extract” without specifying alkaloid content make it impossible to know what dose you’re taking. Check whether 7-hydroxymitragynine is listed separately, and note its proportion relative to total alkaloids. A 7-OH content above 2% of total alkaloids is a red flag for an unusually potent or synthetically boosted product.
Pay attention to serving size. Many bottles that look like single servings actually contain two or three. The difference between drinking one serving and the whole bottle could mean tripling your dose. Because kratom products aren’t federally regulated, label accuracy itself is not guaranteed, and independent testing has found products that don’t match their stated contents.